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DOI: 10.1039/b812429aAn extended multiscale model is introduced for studying the formation of platelet thrombi in blood
vessels. The model describes the interplay between viscous, incompressible blood plasma, activated and
non-activated platelets, as well as other blood cells, activating chemicals, fibrinogen and vessel walls.
The macroscale dynamics of the blood flow is represented by the continuous submodel in the form of
the Navier–Stokes equations. The microscale cell-cell interactions are described by the stochastic
Cellular Potts Model (CPM). Simulations indicate that increase in flow rates leads to greater structural
heterogeneity of the clot. As heterogeneous structural domains within the clot affect thrombus stability,
understanding the factors influencing thrombus structure is of significant biomedical importance.1 Introduction
The hemostatic system has evolved to prevent the loss of blood at
the site of vascular injury. The response is rapid to limit bleeding
and is regulated to prevent excessive clotting that can limit flow.
The processes that are involved in the assembly of a thrombus
(blood clot) include complex interactions among multiple
molecular and cellular components in the blood and vessel wall
occurring under fluid flow.
Formation of a thrombus (thrombogenesis) involves the close
interplay between many processes that occur at different scales
(subcellular, cellular and multicellular, et al.). In the past, these
processes have been studied separately.
The flowing bloodstream over the thrombus affects its growth
and development. Blood carries cellular and molecular compo-
nents to the thrombus for their incorporation into the structure.
These not only include coagulant and anticoagulant proteins but
platelets and blood cells. While histologic analysis of thrombi
formed in vivo reveals the incorporation of leukocytes and
erythrocytes, most models of thrombogenesis fail to include these
cells, viewing them as passive elements entrapped in the clot. On
the other hand, recent evidence suggests that cellular derived
micro-particles in blood are also required for thrombus
formation.
Furthermore, shear forces generated by the flowing blood can
dislodge elements from the structure. Moreover, the growing
thrombus may generate turbulence in the flow field with signifi-
cant consequences to growth properties. Vortices forming behind
the thrombus can trap platelets and blood cells and move them
back towards the clot. This entraps blood cells producing
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cellular and subcellular scale. Endothelial cells respond to
changes in flow. Not only does flow affect cell shape, but it also
influences gene expression patterns. The pattern of gene expres-
sion in endothelial cells cultured under flowing media in vitro is
more typical of resting cells, while inflammatory markers are
expressed by cells growing under static conditions.
Whereas most existing models describe continuous dynamics
at the macroscale related to platelet aggregation and coagu-
lation reactions, there is a reason to believe that many aspects
of the cascade are better modeled as discrete events at the
microscale. First, certain enzymes exhibit threshold effects on
the activation or inhibition of substrate proteins. Second,
some of the more complex aspects of the coagulation process
are poorly understood, and certainly there is no closed-form
set of differential equations for the system as a whole.
Moreover, more coarse-grained information is available at the
microscale, e.g., whether a certain protein factor must be
present at some minimal concentration for a reaction to take
place, and it can be incorporated into the model in the form
of discrete states.
Cell-based discrete models are used in a variety of problems
dealing with biological complexity. One motivation for this
approach is the enormous range of length scales of typical bio-
logical phenomena. The recent book3 reviews many of the cell-
based models. Treating cells as simplified interacting agents, one
can simulate the interactions of tens of thousands to millions of
cells and still have within reach the smaller-scale structures of
tissues and organs that would be ignored in continuum (e.g.,
partial differential equation) approaches. At the same time,
discrete stochastic models including the Cellular Potts Model
(CPM) can be made sophisticated enough to reproduce almost
all commonly observed types of cell behavior.11–13,19,36–37 The
CPM, which is an extension of the Potts model from statistical
physics, can be made sophisticated enough to reproduce almost
all commonly observed types of cell behavior. It has become
a common technique for simulating complex biological problems
including embryonic vertebrate limb development,12,23 tumor
growth17 and vasculogenesis.22Soft Matter, 2009, 5, 769–779 | 769
We believe that various aspects of the development of thrombi
are best studied using a multiscale hybrid model combining
discrete and continuous submodels at different scales. In ref. 38
the authors introduced a basic multiscale two-dimensional model
of thrombus formation. The model combines submodels of all
interrelated factors that contribute to the formation of a blood
thrombus at three spatial scales: 1) the vessel wall scale, assuming
the diameter of the artery to be of the order of 100 microns, 2) the
cellular scale determined by the diameter of a platelet being of the
order of 1 micron, and 3) the inter-cellular scale of the fibrin fibril
network.
The stochastic CPM is used in this model to represent several
types of cells of different sizes and with different adhesivity
properties as well as to describe platelet-injury adhesion, platelet
activation, platelet-platelet binding, cell movement, cell state
changes and platelet aggregation. The incompressible Navier–
Stokes (NS) equations describe dynamics of viscous blood
plasma and the interface submodel couples the CPM with the
continuous model to describe the thrombus-blood plasma
interface. The CPM and the blood flow model respectively are
defined on the lattice and the volume that fills the finite difference
grid. The two computational grids are spatially superimposed.
In this paper, we further develop this multiscale model by
introducing additional types of blood cells and use it to study clot
formation under various flow conditions. In particular, we
describe the impact of flow shear stresses on the final positions in
the thrombi of the cells with different adhesive properties.
Furthermore, we employ the Lagrangian Coherent Structure
(LCS) method (these methods have a long history, with some
related techniques going back to ref. 26. We follow the method of
Haller;16 see the history of this subject in ref. 33 and in ref. 20) to
analyze the detailed flow structure near the clot to reveal the role
of blood flow in clot formation.
The paper is organized as follows. Section 2 provides biolog-
ical background on thrombus development. Section 3 presents
a brief overview of the extension of the multiscale computational
model. Section 4 contains an extended discussion of simulations
and model parameter selection, demonstrates the robustness of
the model and describes blood flow effects on the growth of
thrombus. Section 5 contains the conclusions.2 Biological and modeling background
Following vascular injury, blood is exposed to prothrombotic
environments that promote rapid thrombus formation.
Thrombus formation is the result of two interrelated processes,
namely, platelet interactions and activation of the coagulation
pathway. Immediately after vessel damage, platelets adhere to
the site of vessel injury forming a single cell layer. Platelet
adhesion is promoted by the binding of platelet receptors GpIb/
V/IX to vonWillebrand factor (vWF) and GpIa/IIa and GpVI to
collagen in the subendothelial matrix of the vessel wall. However,
more limited endothelial damage which doesn’t denude the
endothelium and expose the subendothelial matrix also promotes
platelet binding. Conceivably, activated endothelial cells expose
long vWF multimeric chains released from endothelial Weibel-
Palade bodies.
Following adhesion, platelets form multicellular aggregates
mediated by the binding of the platelet GpIIb/IIIa receptor to770 | Soft Matter, 2009, 5, 769–779fibrin(ogen). In addition, platelets undergo activation involving
significant morphological changes, the exposure of new proteins
on the platelet surface and the extracellular release of contents of
alpha and dense granules found in resting platelets. These
contents include a variety of hemostatic proteins and molecules
that stimulate a variety of cells at the site of vessel injury.
Activated platelets also provide a phospholipid surface that
promotes the surface dependent coagulation reactions at the site
of injury.
In addition to platelet interactions, coagulation factor VII(a)
in the blood is exposed to its cellular receptor, TF, expressed on
cells in the vessel wall. Coagulation is initiated when FVIIa
binds to TF. The TF/FVIIa complex catalyzes conversion of FX
to FXa and FIX to FIXa, and initiates a complex network of
reactions that lead to rapid generation of thrombin, which
serves to convert fibrinogen to fibrin, the major matrix protein
in a thrombus, and activates FXIII to cross-link fibrin. In
addition, thrombin triggers a positive feedback loop of propa-
gation reactions. Thrombin is also a potent activator of resting
platelets and thus mediates recruitment of resting platelets
owing nearby in the blood. The activated platelets provide
a procoagulant surface that promotes coagulation enzyme
activity. Making matters more complex, thrombin also activates
the Protein C anticoagulant pathway that inhibits the loop of
propagation reactions by inactivating coagulation factors FVa
and FVIIIa.
In the past, subprocesses involved in thrombogenesis have
been studied as distinct disciplines. For example, the extrinsic
and intrinsic coagulation pathways have been modeled using the
feedback loops described in ref. 18 and 4. The multifaceted
models have been developed based on a large number of reac-
tion-diffusion equations with parameters related to many aspects
of clot growth such as flow rates, membrane binding site density
and concentration of calcium (see ref. 40,39,25). Several models
concentrated on specific aspects of the coagulation. In ref. 6 and
7 it was shown that activation threshold for an enzyme cascade
was affected by the flow rate, the size of the injury and initial
concentrations of active enzymes. The regulation of activation
threshold by levels of Factor-VII and XII and clotting time
sensitivity to zymogen concentrations has been studied using
spatially homogeneous and inhomogeneous systems. Ref. 5 and
40 studied clot growth and dissolution using spatially inhomo-
geneous systems.
There are a few constitutive models of clot formation as well.
A 1D linear viscoelastic clot model has been proposed,21 a 3-D
Maxwell model was developed for the study of coagulation of
whole blood,28 and a Newtonian fluid model in the form of
coupled convection-reaction-diffusion equations without platelet
deposits has been used.14,35 These models neglected the effect of
the growing clot on the flow field. A recent model2 incorporated
both rheological properties of the clot and multiple biochemical
reactions. They modeled clot formation and dissolution as the
growth/diminishment of a singular front (viscoelastic liquid clot)
in a sheer-thinning viscoelastic whole blood region. The
convection-reaction-diffusion equations have been used for
modeling platelet activation, extrinsic coagulation pathway and
fibrinolysis. Due to the extremely complicated nature of blood
clotting, these attempts usually focused on small subsets of the
entire process.This journal is ª The Royal Society of Chemistry 2009
3 Multiscale computational model
Due to the multiscale nature of platelet aggregation and coagu-
lation reactions, capturing both the discrete events and the
continuous mechanics, of thrombus development is best modeled
as a hybrid composition of the two. The multiscale approach
takes advantage of relative simplicity and efficiency of the
macroscopic models, as well as the accuracy of the microscopic
models, and it is particularly helpful for studying the macro-
micro relationships of blood flow and platelet aggregation and
coagulation. It allows one to model in detail formation of the
thrombus as well as a boundary layer between thrombus and
blood flow, resulting in a description of different phases in
thrombus development and of mechanisms determining its shape
and internal structure.3.1 Submodels at different scales
Our model consists of a set of submodels for processes involving
components at scales described in the previous section:
 Biochemical reaction submodel: we use a set of PDEs to
describe the net effect of biochemical reactions.
 Cell submodel: The discrete stochastic CPM represents
different types of cells as well as accounts for platelet-injury
adhesion, platelet activation, platelet-platelet binding, cell
movements, cell state changes and platelet aggregation.
 Flow submodel: The incompressible Navier–Stokes equa-
tions describe dynamics of viscous blood plasma.
 Interface submodel: The submodel couples the CPMwith the
continuous model to describe the thrombus-blood plasma
interface. The CPM and the blood flow model are defined on the
lattice and volume filling finite difference grid respectively. Two
computational grids are spatially superimposed.
The simulation of the thrombus development starts with
utilizing macroscale submodules involving optimized Navier–
Stokes and advection diffusion solvers. Subsequently, obtained
blood flow velocity field and thrombin distribution is fed into the
CPM describing individual cell behavior. On the other hand, cell
differentiation and cell state transition is determined based on
the chemical concentration derived from a sub-cellular module
based on the kinetic equations modeling coagulation pathway.
This information is used when simulating generation of fibril
which eventually form fibrin network. We assume that geometry
of the thrombus (boundary conditions) does not change
considerably during calculation of the flow velocity field. The NS
equations and advection-diffusion equations for the flow and
chemical distributions are solved with this boundary condition
provided by the CPM. The result in turn is used in the subsequent
CPM update. It is also assumed that during the CPM step flow
conditions (velocity and pressure) remain unchanged. The
updated CPM data (interface geometry and chemical concen-
trations) provide new boundary and initial conditions for the NS
advection-diffusion equations modules. The spatial coupling
between cellular and thrombus scales is achieved through mesh
refinement between the CPM cell lattice and the finite difference
grid. The chemical concentration, obtained from the sub-cellular
kinetic equations, is averaged to these grids to reduce the
computational complexity.This journal is ª The Royal Society of Chemistry 20093.2 Stochastic cellular Potts model
The CPM is a cell-level, energy-minimization-based lattice
model, which uses an effective energy E coupled to external
fields, e.g., the local flow rate, to describe cell motion, cell-cell
interactions, cell adhesion, differentiation, division and hapop-
tosis. Each cell consists of many pixels (lattice sites). The distri-
bution of multidimensional indices associated with lattice sites
determines current system configuration. The effective energy of
the system mixes true energies, like cell-cell adhesion, and terms
that mimic energies, e.g., the response of a cell to a blood flow
and the constraint
E ¼ Eadhesion + Eflow + Edim (3.1)
Given an effective energy one can calculate the resulting cell
motion using Metropolis dynamics algorithm based on the
Monte-Carlo Boltzmann acceptance rule.24 More details of the
energy form used in the clot formation modeling can be found
from our previous publication.38
Our model involves eight types of cells (see Fig. 1). ‘‘Injury’’
and ‘‘Vessel’’ cells do not represent cells in the CPM and are used
only to indicate boundary of the vessel domain and place of
injury. During simulation, their positions and adhesion proper-
ties are fixed and platelets can adhere to their surfaces. New
platelets (inactivated) and blood cells are injected from the inlet
(left) side at a specified rate. When cells reach the outlet (right)
side of the simulation domain, they are removed from the system.
We impose the ‘‘no-flux’’ boundary condition on both upper and
lower boundaries so that cells would not move outside of the
domain.
When an inactivated platelet reaches the cite of the injury or
the ADP concentration of a platelet becomes higher than the set
threshold value, it changes its type to ‘‘activated’’ and starts
releasing thrombin which causes fibril generation. Generated
fibrils gradually form fibril network which increases thrombus
stiffness and prevents platelets from detaching from the
thrombus surface. The fibril level in the thrombus and activated
platelet cluster increases with the increase in thrombin concen-
tration. Thus, clusters consisting of activated platelets, have
different fibril levels and stiffness properties at initial and later
stages. In our CPM, we implement two different activated
platelet states (activated platelet and activated platelet with high
fibril level), with different flow responses.38
Platelet adhesion is mediated by plasma proteins bridging
receptors on adjacent platelets (gpIIbIIIa fibrinogen, vironect-
ing, von Willebrand Factor, gpV1-collagen, etc). It is difficult to
describe all details of cell-cell adhesion in the model. In the CPM
the cell-cell adhesion is described as an energy penalty function
term: low cell-cell adhesion energy represents strong adhesivity
between cells while high cell-cell adhesion energy represents weak
cell-cell adhesivity.
In the CPM, the adhesion energy is calculated by
Eadhesion ¼
X
ði;j;kÞ;ði';j';k'Þneighbors
JsðsÞs 'ðs 'Þð1 dðsði; j; kÞ; s'ði'; j'; k'ÞÞÞ;
(3.2)
where d(s,s0) ¼ 0 if s s s0, and d(s,s0) ¼ 1 if s ¼ s0. These
conditions ensure that only the surface sites between differentSoft Matter, 2009, 5, 769–779 | 771
cells contribute to the adhesion energy. Each term under
summation sign is a product of the binding energy per unit
length, Jt(s)t0(s0), and the length of a contact between two
neighboring cells. Adhesive interactions act up to second-near-
est-neighbors. Ref. 15, 27 and 29 show that the adhesivity
between platelets and thrombus is strongly affected by the flow
shear rate on the thrombus surface. At low shear rate, the value
of adhesivity is low and it becomes higher with the increase of the
shear rate, eventually to a constant value. To describe the
dependence of the adhesivity on the shear rate, Jt(s)t0(s0) is
described as a function of the flow shear rate _g on the thrombus
surface:
JsðsÞs 'ðs 'Þ

_g
 ¼
8<
:
Jh þ Je _gh  _g
_gh  _gl
; _g  _gt1
Jh _g  _gt1
(3.3)
where _gh and _gl are the high and low thresholds values of the
shear rate, and Jh and Je are adhesion energy constants.
3.3 Continuous submodels of blood flow and biochemical
reactions
Blood is a complex mixture of cells, proteins, lipoproteins and
ions by which nutrients and wastes are transported. Red blood
cells comprise approximately 40% of blood by volume. In
contrast to water, blood does not exhibit a constant viscosity at
all flow rates and is non-Newtonian in the microcirculatory
system (in small branches and capillaries). The normal blood
flow is laminar with secondary flows generated at curves or
branches. The Reynolds number varies from 1 in small arterioles
to approximately 4000 in the largest artery. Moreover, the blood
flow and pressure are unsteady, since the heart creates pulsating
conditions in all arteries. Depending on the artery and the flow
being modeled, the following main features are usually addressed
in a comprehensive blood modeling effort: vessel wall elasticity,
non-Newtonian viscosity, Fahraeus–Lindquist effect, motion of
particles in the fluid, Fahraeus effect, body forces, and temper-
ature. The Fahraeus–Lindquist effect accounts for the blood
viscosity dependence on the diameter of the vessel it travels
through. The Fahraeus effect is present when blood flows from
a large reservoir into a small circular cylindrical tube. As a result
the hematocrit in the tube is smaller than that in the reservoir.
Since we model the development of thrombus inside a blood
vessel of length approximately 10 times larger than the its
diameter, in our model, we simplify the vessel to be a straight
pipe. The vessel wall is assumed to be a rigid wall. Blood plasma
is treated as an incompressible fluid, which is modeled by the
two-dimensional incompressible Navier–Stokes equations that
take the formTable 1 Coefficients of chemical components and source terms of equations
Species Di/cm
2 s1
ADP 2.56  106
TxA2 2.14  106
Prothrombin [PT] 3.32  107
Thrombin [T] 4.16  107
ATIII 3.49  107
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v
u
vt
þ ð vu ,VÞ vuþ 1
r
Vp ¼ m
r
V2
v
uþ vf (3.4)
V ,
v
u ¼ 0 (3.5)
where
v
u ¼ ðu; vÞ is the flow velocity, r is the density of the
blood plasma, p is the pressure, and m is the viscosity. We
impose the Dirichlet boundary condition (u,v) ¼ (0,0) on
no-slip boundaries.
The major goal of the paper is to study how blood flow affects
developing clots. For this reason, we apply a simple phenome-
nological model to describe the biochemical processes in the form
of the following system of reaction advection-diffusion equa-
tions35
vCk
vt
þ V,ðCk
v
u Þ ¼ DkV2Ck þ Sk; k ¼ 1; 2; :::; 5 (3.6)
where Dk is a diffusion coefficient of the k-th chemical compo-
nent. Sk is the reaction source term of the k-th chemical
component due to the enzymatic reactions. This model is
comprised of equations describing platelet released agonist,
adenosine diphosphate (ADP), and synthesized agonist, throm-
boxane (TxA2), which can be inhibited via 1st order reactions;
prothrombin; thrombin; and antithrombin III (ATIII), which
inhibits thrombin.
Table 1 lists coefficients of chemical components used in the
equations, the source terms and initial concentrations in blood.
Here symbol Ck represents chemical concentration, [AP] and
[RP] are concentrations of the activated and resting platelets,
which are computed from the discrete CPM. (See ref. 35 for the
parameter values appearing in the source term.)
The activation condition for the platelets depends on the
concentrations of the chemical components as well as blood flow
conditions. Platelet activation is partially triggered by the
exposure to shear stresses which are higher than certain threshold
values.10 In the problems studied in the paper, stresses are lower
than the threshold values.
We assume that activation of platelets occurs when the
concentration of chemical components is higher than a specified
threshold. The valid activator concentration is calculated
according to:35
U ¼ ½ADP½ADPcrit þ
½TxA2
½TxA2crit þ
½Thrombin
½Thrombincrit (3.7)
where acrit is the threshold concentration of that agonist for
platelet activation, which is obtained from ref. 35. Once the valid
activator concentration U around a platelet is higher than the
threshold value Ta, the platelet is activated.Si Init. Conc.
likpa[RP]  k1,j[ADP] 0.0 mM
spj[AP]  k1,j[TxA2] 0.0 mM
b[PT](fat[AP] + frt[RP]) 1.0 mM
G[T] + [PT](fat[AP] + frt[RP]) 0.0 U
Gb[T] 2.844 mM
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3.3.1 Parabolic and pulsatile flow models. There is evidence
that vascular fluid dynamics plays an important role in the
development of the thrombus. To mimic physiological flow
conditions, we used a sinusoidal time-dependant velocity func-
tion to model the effect of pulsatility. We impose on the inlet
section that
u ¼ u0(1.0 + 3 sin(wt)) (3.8)
where u0 is mean velocity and 3 is an amplitude of the pulsatility
relative to the mean velocity. The period of oscillation is w ¼ 1 s.
We also assume that the upstream flow is laminar and has
a parabolic profile, resulting in the following inlet velocity
uðhÞ ¼ u

1:0þ 1:44
ﬃﬃﬃ
f
p
þ 2:15
ﬃﬃﬃ
f
p
log10

1 2h
D

; (3.9)
v ¼ 0.0 (3.10)
where u(y) is a x-velocity component at a distance h from the
center of the pipe on the inlet, v is a y-velocity component, D is
diameter of the pipe and f is the friction factor, which is set to be f
¼ 0.01. In general, the friction factor depends on the Reynolds
Number of the pipe flow. Here we assume that the Reynolds
Number is moderate and the inner side of the blood vessel is
smooth in the upstream flow direction.
3.3.2 Non-Newtonian blood viscosity model. To identify the
role of the non-Newtonian property of the blood, we imple-
mented widely used Carreau-Yasuda model8 for the blood
viscosity
m

_g
 ¼ mN þ ðm0  mNÞ1þ l _ga	ðn1Þ=a (3.11)
where viscosity m is a function of the shear rate _g ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2D : D
q
with the following rate of deformation tensor
D ¼ 1
2

V
v
uþ ðV vu ÞT

: (3.12)
Here a, n and l are empirically determined parameters.
In this paper we use the following values a¼ 2, n¼ 0.3568, l¼
3.313 s. Parameters mN and m0 are chosen as mN ¼ 0.0345 g cm1
s1 and m0 ¼ 0.56g cm1 s1 respectively. These parameter values
were taken from a study of the pulsatile flow of blood through
stenotic arteries.1 The calibration of these parameter values was
carried out by a simulation study to show the rheological
behavior of blood flow and to calculate the magnitude of the wall
shear stresses. In simulations with blood being treated as New-
tonian flow, the viscosity m value is set at m ¼ 0.04 g cm1 s1
based on the experimental data.
3.4 Coupling between continuous and discrete submodels
3.4.1 Thrombus-plasma interface. We use volume of fluid
approach to explicitly track the interface between developing the
thrombus (or platelet aggregates at an earlier stage) and blood
plasma. A thrombus, in principle, can be treated as a gel-like
matter, and exhibit viscoelastic behavior. In this paper, we make
the following assumptions to simplify the description of the
interactions:This journal is ª The Royal Society of Chemistry 2009 Blood plasma (the liquid phase) and the thrombus (visco-
elastic matter phase) are assumed to be separated by a sharp
interface called thrombus-plasma interface.
 It is also assumed that within a time step of the Navier–
Stokes PDE solver, the thrombus domain does not change.
Based on these assumptions, we solve Navier–Stokes equa-
tions to update the flow velocity and pressure fields inside
thrombus domain which is fixed during a time step of the PDE
cycle. The updated velocity and pressure fields, in turn, drive the
cells’ motion and aggregation, resulting in thrombus shape
change during the subsequent CPM time step.
All cells in the simulation domain are divided into two types:
cells floating in blood stream and cells on the thrombus. We use
two different methods to handle cell-fluid interactions for two
types of cells. Floating cells are not connected to each other and
it would be very computationally expensive to take all individual
cell geometries into account in solving the Navier–Stokes equa-
tion. The effects of the small floating cell on the blood velocity
distribution are very weak and are ignored in our model to save
calculation time. We do not take floating cells into account in the
boundary condition setup for Navier–Stokes equations. The
motion of floating cells is calculated from the blood velocity
distribution and the flow energy of floating cells depends on the
blood velocity. The cells that are located on the thrombus are
connected to each other by fibers and are treated as a stiff
obstacle in solving the Navier–Stokes equations. Since they are
treated as the stiff boundary, the blood velocities for thrombus
cells are zero and the motion of them cannot be determined from
the blood velocity. We use the blood pressure to determine the
thrombus cells’ motion, and the flow energy term of the
thrombus cells depends on blood pressure. The blood pressure
on the cells that are located on the thrombus boundary is non-
zero and drives them to move towards the interior of the
thrombus, compressing internal thrombus cells. However,
the volume constraint on the internal thrombus cells resists the
compression from the outside cells and the balance between two
trends is obtained from the energy-minimizing principle of the
CPM.
The evolution of the interface between thrombus and blood
plasma is driven by the platelet aggregation and coagulation and
its dynamics is described by the CPM. To track the interface, we
superimpose the CPM cell lattice (grid) on and align with the
PDE grid (see Fig. 2).
The thrombus-plasma interface is identified on the CPM
lattice as a union of outer boundaries of cells located in the
current surface of a thrombus. The interface is projected onto the
PDE grid to provide boundary conditions for the PDE solution
step. We employ no slip boundary conditions.
3.4.2 Impact of the blood flow on a moving cell. We use the
flow energy term in the CPMHamiltonian to describe the impact
of the blood flow on the cells. The flow energy terms for different
types of cells are calculated from the flow velocity distribution or
flow pressure.
Cells with high level of fibril concentration are very stiff and
aggregate together to form the thrombus. In this model, they are
treated as obstacles for the blood flow. The flow force applied to
one of these type cells is calculated as an integral of blood
pressure along a cell membrane:Soft Matter, 2009, 5, 769–779 | 773
Table 2 Simulation parameters
Quiescent platelet–quiescent
platelet adhesion energy
20.0
Activated platelet–activated
platelet adhesion energy
8.0
Activated platelet (high fiber
level–low fiber level)
adhesion energy
15
Volume energy constant 2.0
Fluid energy constant Ke1 ¼ 25.0, Ke2 ¼ 0.2
Threshold1 1.0
Threshold2 6.0
Simulation domain 250 mm  25 mm
CPM grid size 1250  125v
Fi ¼
X
All cell-blood interface
segments k of cell i
pk,
v
nkSk (3.13)
where pk is the pressure applied to the blood-cell interface
segment k,
v
nk is the inward unit normal of blood-cell interface
segment k, and Sk is the membrane length of the blood-cell
interface segment k. For a state change attempt, the flow energy
change for the cell i is
DEflowðiÞ ¼ Ke1
v
Fi,D
v
di (3.14)
where D
v
di is the change in the position of the center of mass of
cell i caused by the state change attempt and Ke1 is a flow energy
constant.
The highly mobile cells (e.g. resting platelets) are separately
distributed in the blood flow and it would be computationally
expensive to calculate the flow distribution around each indi-
vidual cells using the Navier–Stokes equation. The size of these
types of cells is very small and the effects of them on the flow are
negligible. We assumed that these cells have the same velocity as
the those in the flow. Thus, the average flow velocity for a cell i is
v
Vi ¼
X
All pixels of cell i
v
vk=Voli (3.15)
where
v
Vi is the velocity of cell i,
v
vk is the flow velocity at cite k
and Voli is the volume of cell i. The flow energy change for cell i
caused by state change is equal to
DEflowðiÞ ¼ Ke2
v
Fi , D
v
di (3.16)
where D
v
di is the change of the center of mass of cell i caused by
the state change and Ke2 is a flow energy constant.
3.4.3 Coupling time scales of continuous models and CPM.
The CPM is an extension of the Potts model which does not
explicitly indicate its physical time scale. The time scale is
imposed on the CPM by matching the simulated dynamics with
the real physical one. In this model, the moving velocity of
a platelet is assumed equal to the blood value calculated from the
Navier–Stokes equation. Thus the time scale between the CPM
and the continuous model is established by matching the simu-
lated platelet moving velocity with the blood flow velocity.
During the parameter calibration process, we gradually adjust
the flow energy constant value in the CPM until the platelet
moving velocity matches the blood’s. Using the calibrated flow
energy constant ensures that the CPM and the continuous model
are in the same time scale.
3.5 Analysis of the blood flow
To study transport during the formation of the clot we make use
of Lagrangian coherent structures (LCS). For the present anal-
ysis, constituents in the clotting process are assumed to be
transported by the flow generated by the velocity field of the
fluid. That is, letting
v
vð vxðtÞ; tÞ denote the velocity field obtained
from solving the Navier–Stokes equations, the key constituents
in the blood are assumed to be transported according to
v
xðtÞ ¼ vvð vxðtÞ; tÞ (3.17)774 | Soft Matter, 2009, 5, 769–779This assumption is reasonable based on the timescale of the
dynamics considered, and based on the size and mass of the cells
and proteins affecting clot formation.
Letting fð vxðtÞ; t; sÞ : vxðtÞ/ vxðtþ sÞ denote the flow map
generated by integrating eqn (3.17), we can define the finite-time
Lyapunov exponent (FTLE) as
sð vx; t; sÞ ¼ 1
s






dfð vx; t; sÞ
d
v
x





 (3.18)
Here the norm kAk of a matrix A is defined as kAk2 ¼ lmax(A*A),
where lmax is the max eigenvalue. The spatial distribution of the
FTLE can be used to define separatrices in the flow known as
LCS.26,16,33,20 Under this framework LCS are defined as curves
that locally maximize the FTLE in the direction normal to the
curve.33 A positive integration time (i.e. t > 0) used to compute
the FTLE field reveals a repelling LCS, whereas integrating the
particle position backward in time (i.e. t< 0) reveals an attracting
LCS in the FTLE field. Often, LCS defined in this manner are not
sensitive to variations in integration time. However, when the
flow becomes turbulent and the flow structure changes rapidly,
more care must be taken in choosing an appropriate integration
time. More details about the choice and influence of the inte-
gration time can be found in ref. 33,30 and 20.
The advantage of this method is that LCS defines boundaries
between regions of fluid that have distinct dynamics. This can
help to identify the boundary of recirculation regions, vortex
boundaries, or where separation or reattachment of the flow
occurs in a precise manner. Such concepts are difficult or
ambiguous to define using standard criteria in flow analysis when
the system is unsteady, see e.g. ref. 31,32,34.4 Simulation results
In this section we describe simulations which have been per-
formed to study clot development under various flow conditions.
Table 2 lists simulation parameter values.
The coagulation reaction pathway reaction rates and initial
chemical concentrations are from ref. 35 and 9. We used the U
(activation function) from ref. 35 to determine the platelet state
transition in Fig. 3.4.1 Clot growth under parabolic flows
To validate the computational model, we compared the simula-
tion results with the experiments conducted by Begent and Born,9This journal is ª The Royal Society of Chemistry 2009
Fig. 3 Cell state transition map.
Fig. 4 The effect of blood flow rate on clot growth. The clot size refers to
the number of platelets the thrombus is composed of at time 25 s.
Fig. 1 Different types of cells in the model of thrombus development.
Fig. 2 Diagram of the thrombus-plasma interface. a) The thrombus-
plasma interface in the simulation. b) Spatially coupled finite difference
grid and the CPM lattice.in which they found that the size of the resulting thrombus first
increased and then decreased with increase of blood flow
velocity. We ran simulations with different mean blood flow
velocities ranging from 200 mm s1 to 1200 mm s1 to select free
parameters in our model and test whether our model was capable
of reproducing this result. We set 3 ¼ 0 to eliminate the pulsatile
flow effect from this bench mark simulation. In addition, we also
investigated clot development under blood flows with different
viscosity values (m ¼ 0.04, 0.02, 0.01, 0.005 Poise). We were ableThis journal is ª The Royal Society of Chemistry 2009to reproduce the trend of the clot growth and show that it was of
the same order of magnitude as in the experiment.
Fig. 4 shows distribution of sizes of simulated clots in numbers
of coagulated platelets obtained after 25 s, for different blood
flow velocities and viscosities. For normal blood viscosity of m ¼
0.04 Poise, the simulation result is very similar to the experi-
mental result described in ref. 9 (Fig. 4b). Simulations demon-
strated that growth of the thrombus was strongly affected by two
competing factors: the rate at which platelets were supplied by
the blood flow to the thrombus, and intensity of shear force
which prevented platelets from adhering to the thrombus. When
the blood flow rate is low, platelets supply rate plays dominant
role. When blood flow rate is high, the shear force increases to
such an extent that it prevents platelets from adhering to the
thrombus.
Simulations also demonstrated that growth of thrombi was
not greatly influenced by the blood viscosity. In a reasonably
wide range of values of viscosity (0.01 # m # 0.04), growth of
thrombi showed similar characteristics.4.2 Clot growth under Newtonian pulsatile flow
Fig. 5 displays clot size vs. various flow rates, viscosities and
pulse strengths. Notice that under the normal blood viscosity (m
¼ 0.04 Poise), clot development has similar characteristics. For
the pulse strength varying between 0.0 and 0.6, the maximum of
the clot size occurs at the flow rate between 400 mm s1 and 600
mm s1. On the other hand, for the extremely low viscosity (m ¼
0.005 Poise), clot development has different characteristics.
When there is no pulse, clot size first increases with respect to the
increment of the flow rate, then at flow rate of 1000 mm s1 it
reaches its maximum, and then starts to decrease. However, clot
size keeps increasing as the flow rate increases for the pulse
strength of 3 ¼ 0.2, 0.4 and 0.6 respectively.
For the fluid viscosity between 0.04 Poise and 0.005 Poise, the
pulsatile flow changes the dynamics of the clot development
quantitatively but not qualitatively. This means that for different
pulse strength, the maximum of the clot size occurs at different
flow rates. Nevertheless, for viscosity m¼ 0.02 and 0.01 Poise, the
size of the resulting thrombus still first increases and then
decreases with increase of blood flow velocity.Soft Matter, 2009, 5, 769–779 | 775
Fig. 5 The effect of pulse parameters and viscosity on clot growth. The pulse strengths are: (a) 3 ¼ 0.2, (b) 3 ¼ 0.4, and (c) 3 ¼ 0.6 respectively. The clot
size is given in number of platelets in the thrombus after 25 s.4.3 Clot growth under non-Newtonian pulsatile flow
Fig. 6 displays clot size vs. various flow rates for pulse strengths
(3 ¼ 0.0, 0.1 and 0.2). After comparing with Fig. 4 we observe
that, in the absence of a pulse, non-Newtonian flow effect is
negligible within the range of flow rates we study. Moreover,
when pulse strength is small (3¼ 0.1), the growth of the clot is not
affected by the pulsatile flow. However, increase in the strength
of the pulsatile flow changes clot size dramatically. When pulseFig. 6 The effect of non-Newtonian flow on clot growth. The pulse
strength is 3 ¼ 0.0, 0.1, 0.2 respectively. Clot size refers to the number of
platelets the clot is composed of after 25 s.
776 | Soft Matter, 2009, 5, 769–779strength is 3 ¼ 0.2, clot size is significantly smaller. (See Fig. 6 for
a comparison.)4.4 Distribution of cells in clots formed with different flow rates
Clots in Fig. 7 and Fig. 8 simulated for the flow rates from 0.1 cm
s1 to 20.0 cm s1 all have inhomogeneous internal structure. At
the same time, the positions of clusters of blood cells are very
different. Namely, most blood cells are located in the middle of
the clot in Fig. 7a, in the upper part of Fig. 7b and in the lower
part of Fig. 7d. This shows that formulation of the internal clot
structure is significantly influenced by the blood flow.
To simplify the analysis of the clots’ internal structure we
divide it into two equal parts (front and back) and compare
numbers of blood cells in those parts. For low blood flow rates
(0.1 cm s1 and 1 cm s1), the number of blood cells in the front
part is higher than in the back part (the ratio is higher than 1.0).
For high blood flow rates (>1.0 cm s1) the ratio is close to 1.0,
implying that blood cells are homogeneously distributed in the
front and back parts. For a flow rate of 20.0 cm s1, flow vorticity
is observed to bring some platelets to the back side of the clot.
However, the flow vorticity is weak and flow does not flush larger
blood cells to the back side of the clot.
The effect of the low rate on the complexity of the clot struc-
ture is observed in the development of thrombi generated
following vascular injury in experimental animals. Fig. 7f is
a frame from a video monitoring a single optical plane throughThis journal is ª The Royal Society of Chemistry 2009
Fig. 7 The effect of flow rate on the blood cell distribution inside the clot. Flow rates v are (a) v ¼ 0.1 cm s1.
Fig. 8 The effect of flow rate on the blood cell distribution inside the
clot. For each simulation in Fig. 7, we divide the clot into two equal front
and back parts. The flow is from the left (front part) to the right (back
part). The ratio r is defined by r ¼ Nfront/Nback, where Nfront and Nback
represent numbers of blood cells in the front and back parts of the clot,
respectively.a clot developing in a mouse mesenteric vessel following a laser
induced injury. The frame shows a heterogeneous structure that
includes platelets (green) and fibrin (blue) as well as blood cells
(black ‘‘holes’’ excluding dextran (red) in blood). The role of
perturbations in the flow field leading to the entrapment and
incorporation of blood cells and the irregular thrombus structure
is more evident in the video recording than in a single frame. The
ability of the simulation to predict the effect of flow on clot
structural features is the subject of future studies.4.5 Analysis of the blood flow near the clot
Here we apply the methodology described in Section 3.5 to
understand the role of the blood flow near the clot. Fig. 9 plots
the forward-time FTLE field at 6 instances during the clot
formation stage. There is a well-defined repelling LCS that exists
throughout the clotting process, which is defined by the curve of
high FTLE (shown in red). Proximal to the clot, the LCS remains
close to the vessel wall. Nearing the clot, the LCS extends towardThis journal is ª The Royal Society of Chemistry 2009the center of the vessel and encloses a region that contains both
portions of the blood clot. This LCS appears to terminate on the
distal portion of the clot, away from the vessel wall. Distal to the
second portion of the clot, there exists a separate LCS, which
terminates on the vessel. The integration time used to compute
the FTLE fields was t ¼ 0.3 s.
In the case where the peak free-stream flow speed is 0.1 cm s1,
there is no recirculation present behind the clot throughout the
clotting process. The Reynolds number for this flow is Re ¼
0.001, based on the vessel diameter and average flow speed.
Therefore, the flow is highly viscous and is able to remain
attached downstream from the clot.
For the case where the peak free-stream flow speed is 5 cm s1,
two clots that are initially separate, but close, form and quickly
combine to form a single clot. As these clots develop, an interior
region of recirculation exists between them. This region is bound
by the repelling LCS shown in Fig. 9 that propagates proximal to
the clot region close to the vessel wall and covers the majority of
the region where the clot develops. Therefore no transport occurs
between this interior recirculation region and the surrounding
blood flow, except entrainment of flow near the vessel wall. This
thin layer of blood bound by the LCS proximal to the clotting
region also constitutes fluid that eventually grows the clot. Distal
to the clot, there is a small region of recirculation. This small
recirculation region is partially bound by a separate repelling
LCS that terminates on the vessel wall downstream from the clot.
This LCS is separate from the primary LCS bounding much of
the clotting region. The gap between this LCS and the distal side
of the clot permits entrainment and detrainment between this
small region of recirculation behind the clot and the ambient
flow. However, the rate of entrainment and detrainment is small
during the clotting process and does not appear to affect the clot
formation significantly.5 Conclusions
Since the hemostatic system has evolved to stem the loss of blood
following damage to blood vessels, understanding the parame-
ters affecting clot structural integrity has important biomedicalSoft Matter, 2009, 5, 769–779 | 777
Fig. 9 Forward-time FTLE field at 6 instances during clot formation. A well-defined LCS is present that defines the boundary between the region of
blood propagating downstream and blood that recirculates and clots. The integration time used to produce these plots was t ¼ 0.3 s.implications. Furthermore, intravascular clots formed in
response to damage that does not cause vessel rupture presents
potentially serious pathological conditions. These intravascular
clots (thrombi) can grow and restrict blood flow, causing
pathology in the tissues supplied by the vessel. Additionally,
unstable thrombi can shed emboli (clot fragments) that can
embed in vessels of the lungs or brain potentially causing
pulmonary embolisms or ischemic strokes, respectively. These
conditions result in a significant number of deaths in the US, and
the rate is expected to increase as the population ages.
This paper describes the incorporation of additional hemo-
dynamic complexity into a computational model of thrombus
development first introduced in ref. 38. Simulations using this
updated model indicate that increasing flow rates lead to greater
structural heterogeneity. These irregular clots include domains
with distinct compositions and with different mechano-elastic
properties. Differential compression by adjacent domains in
response to changing forces on the thrombus can lead to frac-
tures at the interface between domains.
We used LCS to determine the region of blood that is trans-
ported to the clot. (We only considered the kinematic affect of
the blood flow on transport near the clot.) The computation of
LCS can also be applied to three-dimensional data,20 as has
already been done in other cardiovascular applications.34 Qual-
itatively, we expect future computations of LCS using three-
dimensional blood clot formation data will reveal similar regions
of recirculation and transport mechanisms. The typical Reynolds
numbers for flow around the clots considered here are sufficiently
low that we do not expect any transition to turbulence for three-
dimensional flow. However, the rough surface of the blood clot
often leads to complex secondary instabilities for the flow near778 | Soft Matter, 2009, 5, 769–779the clot. Moreover, previous experience in applying these
computation to three-dimensional blood flow data leads us to
expect that the three-dimensional simulations may reveal more
complex stirring of the blood in the vicinity of the clot due to the
increase degree of freedom of transport. This hypothesis will be
investigated further in our future work on three-dimensional
blood clot formation simulations.
We are currently working on a three dimensional extension of
the multiscale approach and incorporating into the model
platelet specific dynamics and the biochemical effects influencing
platelet transport near the clot boundary. To study these
dynamics, a much more highly resolved understanding of the
flow must be obtained near the clot boundary, which requires
a fully resolved three-dimensional calculation.
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